Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus
A Year to Remember: Dr. Jinoos Yazdany Presents the 2020 Clinical Research Review
In Wake of Lupus Trial Failure, New Research Attacks From Many Angles
The Type I Interferon Pathway’s Influence in Connective Tissue Disease
Insight into Clinical Trials for Lupus
AstraZeneca Lupus Drug Fails to Meet Main Goal in Study
Effectiveness of Novel Therapies for Cutaneous SLE Explored
